Capital Fund Management (CFM)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 865 |
|
|
2025
Q1 | – | Sell |
-121,433
| Closed | -$3.87M | – | 780 |
|
|
2024
Q4 | $3.87M | Sell |
121,433
-121,801
| -50% | -$3.89M | 0.01% | 459 |
|
|
2024
Q3 | $7.01M | Buy |
243,234
+41,747
| +21% | +$1.2M | 0.02% | 280 |
|
|
2024
Q2 | $7.73M | Buy |
+201,487
| New | +$7.73M | 0.02% | 248 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 682 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 714 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 655 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 614 |
|
|
2023
Q1 | – | Sell |
-12,884
| Closed | -$666K | – | 565 |
|
|
2022
Q4 | $666K | Buy |
+12,884
| New | +$666K | ﹤0.01% | 467 |
|
|
2022
Q2 | – | Sell |
-10,620
| Closed | -$540K | – | 628 |
|
|
2022
Q1 | $540K | Buy |
+10,620
| New | +$540K | ﹤0.01% | 532 |
|